NCT02802475 - Antibodies Causing Epilepsy Syndromes: The ACES Study. | Biotech Hunter

Enrollment

582

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2020

Conditions

Auto-immune EncephalitisEpilepsy

Interventions

BIOLOGICAL

vena punction

Trial Locations (8)

Epilepsiecentrum Kempenhaeghe, Heemstede

Stichting Epilepsie Instelling Nederland (SEIN), Heemstede

Academic Hospital Maastricht, Maastricht

Erasmus Medisch Centrum, Rotterdam

Maasstad Hospital, Rotterdam

Haga Hospital, The Hague

St. Elisabeth Hospital, Tilburg

UMCU, Utrecht